Case-control study of second-line therapies for type 2 diabetes in combination with metformin and the comparative risks of myocardial infarction and stroke.
Diabetes Obes Metab
; 17(12): 1194-7, 2015 Dec.
Article
in En
| MEDLINE
| ID: mdl-26179389
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Sulfonylurea Compounds
/
Stroke
/
Diabetes Mellitus, Type 2
/
Hypoglycemic Agents
/
Insulin
/
Metformin
/
Myocardial Infarction
Type of study:
Etiology_studies
/
Guideline
/
Incidence_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Country/Region as subject:
America do norte
Language:
En
Journal:
Diabetes Obes Metab
Journal subject:
ENDOCRINOLOGIA
/
METABOLISMO
Year:
2015
Document type:
Article
Affiliation country:
United States
Country of publication:
United kingdom